Pharmafile Logo
Pharmafocus logo
Advanced Search

drugs

Showing 15 posts of 771 posts found.

amazon_-_image_silus_grok_-_flickr

Amazon puts selling pharmaceuticals plan on back-burner

April 17, 2018
Manufacturing and Production, Sales and Marketing amazon, biotech, drugs, pharma, pharmaceutical, pharmacy

Last year buzz about Amazon entering the pharmaceutical distribution market steadily grew after it obtained pharmacy licenses in a small …

News
bill_chin_headshot

Frequency Therapeutics hires industry vet

April 16, 2018
Manufacturing and Production, Medical Communications Frequency Therapeutics, biotech, drugs, pharma, pharmaceutical

Frequency Therapeutics is a biotech with big ideas and it has made a big appointment to back up those ideas, …

News
pharmacy-3087596_960_720

Care packaging: Inside the Falsified Medicines Directive

April 16, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, packaging, pharma, pharmaceutical

When it comes to the pharmaceutical supply chain, patient safety has and will always be a primary concern for all …

Feature

Sanofi looks to trim down with divestments

April 16, 2018
Sales and Marketing Charterhouse Capital, Sanofi, Zentiva, biotech, drugs, pharma, pharmaceutical

Sanofi has begun part of a larger process of slimming down its business with the sales of 12 medicines. It …

News

J&J’s ketamine nasal spray for depression continues to impress

April 16, 2018
Research and Development, Sales and Marketing Johnson & Johnson, Ketamine, biotech, drugs, pharma, pharmaceutical

New treatments for depression are few and far between; pharmaceutical companies have shied away from trying to develop new therapeutics …

News
shire_image

Shire jettisons oncology unit for $2.4bn, unbalancing Takeda deal

April 16, 2018
Sales and Marketing Servier, Shire, Takeda, biotech, drugs, oncology, pharma, pharmaceutical

Shire has announced that it has entered a definitive agreement for French drugmaker Servier to take on its oncology business. …

News
180405-evolution-of-kidney-cancer

Evolutionary path of kidney cancer tracked, “born to be bad” type discovered

April 13, 2018
Medical Communications, Research and Development Kidney cancer, biotech, drugs, pharma, pharmaceutical

A massive effort funded by Cancer Research UK has been able to track the different evolutionary pathways of kidney cancer …

News
roche__tree

Roche’s immunotherapy lucky streak ends with deaths in trial

April 13, 2018
Medical Communications, Research and Development Exelixis, Roche, biotech, drugs, pharma, pharmaceutical, tecentriq

Roche’s Tecentriq had begun to show signs of reviving its hopes in the competitive PD-1/L1 market, succeeding in two Phase …

News
satu1028-pano_1024_px

EMA announces second-ever public hearing on high-use antibiotics

April 12, 2018
Medical Communications Antibiotics, EMA, biotech, drugs, pharma, pharmaceutical

The EMA has announced, following the first-ever public hearing on valproate, that it would hold a second public hearing regarding …

News
hands-981400_960_720

Alzheimer’s protein treatment that works in human cells

April 12, 2018
Research and Development Alzheimer's disease, Gladstone Institutes, biotech, drugs, pharma, pharmaceutical

One of the major stumbling blocks that science has come up against, when trying to develop potential treatments for Alzheimer’s …

News
essure

Bayer contraceptive implant public backlash brings results

April 12, 2018
Medical Communications, Sales and Marketing Bayer, Essure, biotech, drugs, pharma, pharmaceutical

Bayer’s permanent contraceptive device, Essure, has been at the centre of a public backlash for a number of years, with …

News
csm_packshot_kineret_814229b3fc

Sobi receives expanded EU approval for Kineret

April 11, 2018
Research and Development, Sales and Marketing Kineret, anti-inflammatory, biotech, drugs, pharma, pharmaceutical, sobi

Joining its current indication as a treatment for rheumatoid arthritis and cryopyrin-associated periodic syndromes, Sobi’s Kineret has been given approval …

News

Alexion $855m portfolio boost after Wilson Therapeutics buyout

April 11, 2018
Research and Development, Sales and Marketing Alexion, Wilson's Therapeutics, Wilson's disease, biotech, drugs, pharma, pharmaceutical

Alexion Pharmaceuticals is badly in need of alternative revenue streams to Soliris, its mega-blockbuster that could start to face competition …

News
mylan

Mylan looks to hit Teva where it hurts, eyeing slow-release MS treatment

April 11, 2018
Research and Development, Sales and Marketing Copaxone, Mapi Pharma, Mylan, Teva, biotech, drugs, pharma, pharmaceutical

Mylan has taken several steps recently that seem intended to hit sales of its big rivals on their key products, …

News
theresa_may_-_credit_arno_mikkor

May announces £75m prostate cancer boost

April 10, 2018
Manufacturing and Production, Medical Communications Prostate Cancer UK, UK, biotech, drugs, pharma, pharmaceutical, prostate cancer

Prostate cancer has begun to receive more publicity in recent years in the UK, but not for the right reasons. …

News

Latest content

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer

May 17, 2024

AstraZeneca shares results from phase 3 trial of COVID-19 prevention drug

May 17, 2024

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024